BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29746255)

  • 1. A novel functional polymorphism of
    Wang J; Wang ML; Wang CH; Sun SY; Zhang HB; Jiang YY; Xu QW; Wang Y; Gu SX
    Aging (Albany NY); 2018 May; 10(5):988-999. PubMed ID: 29746255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T; Mingyi M; Qiu X; Qiu Y
    Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of miR-1275 by H3K27me3 is critical for glial induction of glioblastoma cells.
    Mai J; Gu J; Liu Y; Liu X; Sai K; Chen Z; Lu W; Yang X; Wang J; Guo C; Sun S; Xing F; Sheng L; Lu B; Zhu Z; Sun H; Xue D; Lin Y; Cai J; Tan Y; Li C; Yin W; Cao L; Ou-Yang Y; Qiu P; Su X; Yan G; Liang J; Zhu W
    Mol Oncol; 2019 Jul; 13(7):1589-1604. PubMed ID: 31162799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
    Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
    Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemo-resistance of A172 glioblastoma cells is controlled by miR-1271-regulated Bcl-2.
    Yang L; Wang Y; Li YJ; Zeng CC
    Biomed Pharmacother; 2018 Dec; 108():734-740. PubMed ID: 30248541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
    Zhang S; Lai N; Liao K; Sun J; Lin Y
    Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.
    Leiss L; Mega A; Olsson Bontell T; Nistér M; Smits A; Corvigno S; Rahman MA; Enger PØ; Miletic H; Östman A
    Glia; 2020 May; 68(5):979-988. PubMed ID: 31769546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.
    Sakata J; Sasayama T; Tanaka K; Nagashima H; Nakada M; Tanaka H; Hashimoto N; Kagawa N; Kinoshita M; Nakamizo S; Maeyama M; Nishihara M; Hosoda K; Kohmura E
    J Neurooncol; 2019 Apr; 142(2):241-251. PubMed ID: 30701354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma.
    Li Y; Li W; Zeng X; Tang X; Zhang S; Zhong F; Peng X; Zhong Y; Rosol TJ; Deng X; Liu Z; Peng S; Peng X
    Oncogene; 2019 Nov; 38(47):7234-7248. PubMed ID: 31477833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
    Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
    Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.
    Cai JJ; Qi ZX; Chen LC; Yao Y; Gong Y; Mao Y
    Oncol Rep; 2016 Jan; 35(1):284-90. PubMed ID: 26530859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
    Li W; Huang H; Su J; Ji X; Zhang X; Zhang Z; Wang H
    Mol Neurobiol; 2017 May; 54(4):2555-2561. PubMed ID: 26993295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.
    Ji Y; Sun Q; Zhang J; Hu H
    Biochem Biophys Res Commun; 2018 May; 499(3):719-726. PubMed ID: 29605294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.
    Liao YC; Liu PY; Lin HF; Lin WY; Liao JK; Juo SH
    J Mol Cell Cardiol; 2015 Feb; 79():180-6. PubMed ID: 25481646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
    Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
    Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.